UniProt ID | Protein Name | Gene Symbol | No. of Glycosylation Sites | No. of GlyTouCan IDs | Disease Ontology ▲ |
---|---|---|---|---|---|
A0A8C0VUU1 | Hyaluronidase |
|
1 | 0 |
|
A0A8C0UJ17 | Proto-oncogene tyrosine-protein kinase receptor Ret |
|
1 | 0 |
|
A0A8C0VX34 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A8C0V509 | Peptidylglycine alpha-amidating monooxygenase |
|
1 | 0 |
|
A0A8C0VYA5 | Phosphoinositide phospholipase C |
|
1 | 0 |
|
A0A8C0VR55 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A8C0VTF2 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A8C0VEV2 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A8C0VSH2 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A8C0ZDC4 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A8C0U5Q4 | Potassium channel subfamily K member |
|
1 | 0 |
|
A0A8C0ZGR2 | Hyaluronidase |
|
1 | 0 |
|
A0A8C0ZKZ6 | Hyaluronidase |
|
1 | 0 |
|
A0A8C0VXK2 | Hyaluronidase |
|
1 | 0 |
|
A0A8C0VVA1 | P2X purinoceptor |
|
1 | 0 |
|
A0A8C0VI45 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A8C0V616 | Peptidylglycine alpha-amidating monooxygenase |
|
1 | 0 |
|
A0A8C0UL87 | Protein adenylyltransferase FICD |
|
1 | 0 |
|
A0A8C0VXU3 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A8C0VQL7 | Pannexin |
|
1 | 0 |
|
A0A8C0ZH61 | Fibroblast growth factor receptor |
|
8 | 0 |
|
A0A8C0VF62 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A8C0UUI7 | Voltage-dependent T-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A8C0UYR8 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase |
|
1 | 0 |
|
A0A8C0UVQ7 | Rhodopsin |
|
2 | 0 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024